Daymark Wealth Partners’s LeMaitre Vascular LMAT Stock Holding History

Daymark Wealth Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$293K	Buy	+3,552	New	+$315K	0.01%	701

Other funds holding LMAT

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Conestoga Capital Advisors Wayne, Pennsylvania $3.31B AUM 6.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return

Daymark Wealth Partners's LMAT Position: Q3 2026 in Review

Daymark Wealth Partners opened a new position in LeMaitre Vascular (LMAT) in Q3 2026: 3,552 shares worth $293K. The stake represents 0.01% of the portfolio and ranks #701 among its holdings.

238 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

Daymark Wealth Partners held 3,552 shares of LeMaitre Vascular worth $293K as of Q3 2026.
LeMaitre Vascular was a new Daymark Wealth Partners position in Q3 2026.
LeMaitre Vascular made up 0.01% of Daymark Wealth Partners's portfolio in Q3 2026, its #701 holding.
238 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Daymark Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.